Patients with hepatitis C virus (HCV) infection present higher risk of developing type-2 diabetes mellitus (DM). However, the mechanism of this association and the role of antiviral treatment are still unclear. The objective of this study was to investigate the relationship between the use of peguil
Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C
β Scribed by Antonio Tursi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 53 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
infliximab. In contrast, similar psoriasiform lesions are reported to have been induced by infliximab in a few patients with inflammatory bowel diseases. [3][4][5][6][7] Such an undesired, dermatologically adverse effect is considered a delayed hypersensitivity reaction that commonly occurs during various anti-TNF-β£ therapies because psoriasiform lesions have also been shown to have been induced by etanercept and adalimumab. Heymann 8 reported that those skin lesions occur mainly on the palms and soles predominantly in women. Because most patients with psoriasis induced by infliximab were treated simultaneously with immunosuppressive agents such as azathioprine or methotrexate, those agents are unlikely to prevent the adverse reaction. Because the precise mechanism of the paradoxical development of psoriasiform lesions during anti-TNF-β£ therapy is still unclear and these lesions are not easy to predict, there is a need to accumulate and analyze more cases of the association.
π SIMILAR VOLUMES
Response-guided pegylated interferon (peg-IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus-infected patients provide contradictory results. We conducted meta-analyses of randomized, controlled trials to address (1) the benefit of a 72-week extended-duration thera
## Treatment of chronic hepatitis C with Interferon (IFN) β£2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated
Response rates to interferon and ribavirin treatment for recipients with recurrent hepatitis C virus (HCV) infection are suboptimal, particularly for those with genotype 1b and high viral load. The present study evaluated the effects of combining double-filtration plasmapheresis (DFPP) with pharmaco
In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated
## Abstract The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient coβinfected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events an